Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
A10 Networks
ATEN
$1.99B
| $1.59M | ﹤0.01% |
105,462
-4,376
| -4% | -$64.8K |
|
1977
Integra LifeSciences
IART
$1.33B
| $1.58M | ﹤0.01% |
41,478
-13,370
| -24% | -$563K |
|
1978
Ameresco
AMRC
$1.36B
| $1.58M | ﹤0.01% |
41,068
+28,832
| +236% | +$1.39M |
|
1979
CALL
Ironwood Pharmaceuticals
IRWD
$701M
| $1.58M | ﹤0.01% |
+164,400
| New | +$1.61M |
|
1980
Community Trust Bancorp
CTBI
$1.42B
| $1.58M | ﹤0.01% |
46,134
+3,176
| +7% | +$116K |
|
1981
Keros Therapeutics
KROS
$211M
| $1.58M | ﹤0.01% |
49,511
+11,118
| +29% | +$415K |
|
|
RPT
1982
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.58M | ﹤0.01% |
149,249
-69,619
| -32% | -$745K |
|
1983
Global E Online
GLBE
$6.89B
| $1.57M | ﹤0.01% |
39,617
+15,733
| +66% | +$633K |
|
1984
Malibu Boats
MBUU
$562M
| $1.57M | ﹤0.01% |
32,104
+1,696
| +6% | +$91.1K |
|
1985
CareTrust REIT
CTRE
$9.72B
| $1.57M | ﹤0.01% |
76,603
-161,811
| -68% | -$3.27M |
|
|
ICVX
1986
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.57M | ﹤0.01% |
202,182
+196,702
| +3,589% | +$1.63M |
|
1987
Preferred Bank
PFBC
$1.25B
| $1.57M | ﹤0.01% |
25,163
+990
| +4% | +$61.8K |
|
1988
Marten Transport
MRTN
$1.21B
| $1.56M | ﹤0.01% |
79,344
-4,029
| -5% | -$85.2K |
|
1989
Abeona Therapeutics
ABEO
$393M
| $1.56M | ﹤0.01% |
371,276
+185,638
| +100% | +$702K |
|
|
VTLE
1990
DELISTED
Vital Energy
VTLE
| $1.56M | ﹤0.01% |
28,203
+7,334
| +35% | +$394K |
|
|
DISH
1991
DELISTED
DISH Network Corp.
DISH
| $1.56M | ﹤0.01% |
266,713
+37,377
| +16% | +$255K |
|
1992
Assured Guaranty
AGO
$3.66B
| $1.56M | ﹤0.01% |
25,718
-468
| -2% | -$27.8K |
|
1993
XPEL
XPEL
$1.31B
| $1.55M | ﹤0.01% |
20,140
-664
| -3% | -$53.4K |
|
1994
Karyopharm Therapeutics
KPTI
$44.2M
| $1.54M | ﹤0.01% |
76,820
+3,063
| +4% | +$68.7K |
|
1995
Prestige Consumer Healthcare
PBH
$2.58B
| $1.54M | ﹤0.01% |
26,994
-1,739
| -6% | -$105K |
|
1996
OSI Systems
OSIS
$3.91B
| $1.54M | ﹤0.01% |
13,077
-566
| -4% | -$68.2K |
|
1997
Casella Waste Systems
CWST
$5.75B
| $1.54M | ﹤0.01% |
20,229
-1,181
| -6% | -$96.8K |
|
1998
Autohome
ATHM
$2.62B
| $1.54M | ﹤0.01% |
50,806
+700
| +1% | +$21.1K |
|
1999
Affirm
AFRM
$25.6B
| $1.54M | ﹤0.01% |
72,309
+3,726
| +5% | +$68.1K |
|
2000
Knife River
KNF
$3.83B
| $1.54M | ﹤0.01% |
31,445
-5,855
| -16% | -$278K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.